NEW YORK (GenomeWeb) – Theranostics Health today announced an agreement with Avera Health to expand research and commercial collaborations on the firm's TheraLink Assay.

The proteomic panel measures the activation of several drug targets and biomarkers associated with commonly prescribed cancer therapies to monitor treatment response.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.